MDxHealth Clinical Laboratory Receives CLIA Certification
MDxHealths 13,448-square-foot clinical laboratory facility in Irvine, Calif, has received CLIA certification of registration from the Centers for Medicare and Medicaid Services.
Read MorePosted by Clinical Lab Products | Jan 23, 2012 | Cancer, Miscellaneous |
MDxHealths 13,448-square-foot clinical laboratory facility in Irvine, Calif, has received CLIA certification of registration from the Centers for Medicare and Medicaid Services.
Read MorePosted by Clinical Lab Products | Jan 23, 2012 | Cancer, Colorectal, Miscellaneous |
The data from the paper demonstrate the value of implementing Previstage testing in patients with colorectal cancer to identify those patients at risk of relapse.
Read MorePosted by Steve Halasey | Jan 14, 2012 | Miscellaneous |
With molecular diagnostics, clinicians leverage sophisticated technology to uncover patterns and interactions of genes and proteins in a cell or organism, and use this information to determine if these patterns signal normal cell growth or diseas
Read MorePosted by Clinical Lab Products | Jan 14, 2012 | Miscellaneous |
With molecular diagnostics, clinicians leverage sophisticated technology to uncover patterns and interactions of genes and proteins in a cell or organism, and use this information to determine if these patterns signal normal cell growth or diseas
Read MorePosted by Clinical Lab Products | Jan 11, 2012 | Cancer, Miscellaneous |
QIAGEN has come to agreements with two US biotech companies to acquire worldwide exclusive rights to biomarkers that are expected to play an important role in personalized treatment of various cancers.
Read More